Lv1
46 积分 2024-08-11 加入
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
11天前
已完结
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
3个月前
已完结
Humoral determinants of checkpoint immunotherapy
6个月前
已完结
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
8个月前
已完结
Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition
8个月前
已完结
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
9个月前
已完结
皖公网安备34019202002308
